ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

11 links0 made here, not in the record21 judgments2 judges (the rules as one: Rule based)1 record change seen
Claude Opus 5.5Rule basedRecord updated on ClinicalTrials.gov
Oct 12Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT04566380ONO-4538 Phase II RolloverStudy (ONO-4538-98)Ono Pharmaceutical Co., Ltd.Phase 2 · recruitingRECORDThe record itselfVersions seen nightly since Sep 25, 2…›Oct 14 · ClinicalTrials.gov record · Version of 2026-10-14Version of 2026-10-14CONDITIONSPan-tumorNo longer in the registry's filing›Nov 14 · Rule based · Not readNot readDRUGSNivolumabEntry “ONO-4538”, read by our name ru…›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedOxaliplatinIntervention entry›Nov 2 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · BackgroundBackgroundTegafurEntry “S-1”, read by our name rule›Nov 2 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · BackgroundBackgroundGimeracilEntry “S-1”, read by our name rule›Nov 2 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · BackgroundBackgroundOxonic AcidEntry “S-1”, read by our name rule›Nov 2 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · BackgroundBackgroundCapecitabineIntervention entry›Nov 2 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · BackgroundBackgroundBevacizumabIntervention entry›Nov 2 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · BackgroundBackgroundTemozolomideIntervention entry›Nov 2 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · BackgroundBackgroundIpilimumabIntervention entry›Nov 2 · Claude Opus 5.5 · Background · establishedNov 18 · Rule based · BackgroundBackground · establishedINT028061Entry “ONO-7703”, read by our name ru…›Nov 2 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · BackgroundBackground

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

Nivolumab

From the registry record2 judgments on this link
Role in the study, from the registry to what was judged
RegistryEntry “ONO-4538”the record gives no role
→judged=agrees
How the 2 judgments split100%of judgments with a known value say Tested
Tested · 2

All judgments on this study

WhenLinkJudgeDecisionState
Oct 14The record itselfClinicalTrials.gov recordVersion of 2026-10-14Record change
Nov 2NivolumabClaude Opus 5.5TestedCurrent
Nov 2OxaliplatinClaude Opus 5.5BackgroundCurrent
Nov 2TegafurClaude Opus 5.5BackgroundCurrent
Nov 2GimeracilClaude Opus 5.5BackgroundCurrent
Nov 2Oxonic AcidClaude Opus 5.5BackgroundCurrent
Nov 2CapecitabineClaude Opus 5.5BackgroundCurrent
Nov 2BevacizumabClaude Opus 5.5BackgroundCurrent
Nov 2TemozolomideClaude Opus 5.5BackgroundCurrent
Nov 2IpilimumabClaude Opus 5.5Background · establishedCurrent
Nov 2INT028061Claude Opus 5.5BackgroundCurrent
Nov 14Pan-tumorRule based · condition-kind ruleNot readCurrent
Nov 18NivolumabRule based · role ruleTestedAgrees
Nov 18OxaliplatinRule based · role ruleBackgroundAgrees
Nov 18TegafurRule based · role ruleBackgroundAgrees
Nov 18GimeracilRule based · role ruleBackgroundAgrees
Nov 18Oxonic AcidRule based · role ruleBackgroundAgrees
Nov 18CapecitabineRule based · role ruleBackgroundAgrees
Nov 18BevacizumabRule based · role ruleBackgroundAgrees
Nov 18TemozolomideRule based · role ruleBackgroundAgrees
Nov 18IpilimumabRule based · role ruleBackgroundAgrees
Nov 18INT028061Rule based · role ruleBackgroundAgrees

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

Which drugs a study tests

Reads each treatment the study lists and the arms it is in. A drug only in the experimental arm is tested. A drug in every arm while something else changes between the arms is given beside it. A drug only in the control arm is the comparator. Placebo, procedures and usual care are known by name.

Where the whole record has been read, that reading's answer replaces the rule's.

How a condition link is counted

For each condition a study is filed under: whether it is the study's own condition at the finest the study states it, a wider one, a general category, or filed by mistake; and whether it is the main condition, a setting the study names, or only how it was filed.

A decision on file for one study overrides it, with who made it and when.